|
SCIENCE IN THE NEWS - January 8, 2002: Top
stories of 2001
By Nancy Steinbach
VOICE ONE:
This is Bob Doughty.
VOICE TWO:
And this is Doug Johnson with the Special English
program SCIENCE IN THE NEWS. Today, we tell about some major science
stories of the year two-thousand-one. We tell about stem cell research,
anthrax bacteria and the disease AIDS.
((THEME))
VOICE ONE:
Last year, President Bush approved limited federal
government support of research on special human cells. The research
involves stem cells taken from fertilized human eggs called embryos.
Scientists believe stem cells may be highly
useful in the treatment and possible cure of many diseases. The most
useful are stem cells from embryos. They are able to develop into all
the kinds of tissues of the body.
Embryonic stem cells are taken from embryos
created in laboratories to help women become pregnant. Scientists use
embryonic stem cells from embryos that are four or five days old.
During those first days, the cells in the embryo divide quickly. For
a short period of time, each of the embryo's cells is able to become
any one of more than two-hundred different kinds of cells in the body.
The great value of embryonic stem cells appears
to be their ability to reproduce in large numbers in the laboratory
before they become specialized cells. Researchers believe that embryonic
stem cells may be used to help diseased organs develop healthy cells
again.
They hope these stem cells can be used to treat
diseases of the brain, heart, liver, pancreas and kidneys. These include
diabetes, Parkinson's disease and Alzheimer's disease.
VOICE TWO:
However, the Bush Administration has only permitted
research on about sixty groups of existing stem cells. Medical researchers
have noted that these groups of stem cells are not useful for treating
disease.
Also, treatments developed from existing stem
cells might be rejected by the bodies of possible patients. This is
because the genetic material is different.
Some scientists say the best way to make stem
cells for treatment is to grow them from embryos that are exact copies
of patients.
Late last year, scientists working for the company
Advanced Cell Technology announced that they had made the first genetic
copies of human embryos. The process of making genetic copies is called
cloning.
Cloning involves the creation of an embryo from
a single adult cell. Genetic material from the adult cell is joined
with an egg cell whose genetic material has been removed. Scientists
have used cloning to create animals.
Scientists from Advanced Cell Technology performed
the experiments in an effort to create cloned human embryonic stem cells.
However, the experiments did not produce stem cells because the embryos
did not live long enough.
Company officials said the research on human
embryos is designed only to produce embryonic stem cells to treat disease.
They have strongly stated that the company has no interest in cloning
human beings.
VOICE ONE:
American lawmakers have been preparing legislation
that could ban or limit cloning. President Bush said he strongly opposes
human cloning. He said it is wrong to use embryos for cloning. The Catholic
Church opposes all kinds of stem cell research.
Many other religious groups also oppose all
embryonic stem cell research. They consider it the same as taking a
human life. Other religious groups accept the research with several
restrictions because it may lead to cures for some diseases.
Experts say the debate about embryonic stem
cell research is complex and will continue for some time.
((MUSIC BRIDGE))
VOICE TWO:
Another major scientific story of Two-Thousand-One
involved the disease anthrax. The deadly bacterium that causes the disease
was found in letters mailed within the United States.
These letters were sent to several places, including
major news organizations and congressional offices. This led to the
closing of several government buildings and mail centers. Federal investigators
say the anthrax was sent through the mail in an organized act of biological
terrorism.
Letter to Senator Tom Daschle
Several people died as a result of breathing the anthrax bacteria into
their lungs. Many other people are still taking medicines to protect
against the disease if anthrax was found in buildings where they work.
Most recently, federal health officials have
offered anthrax vaccine and more medicine to thousands of affected people.
The fear is that the anthrax bacteria may still be present in their
lungs even after taking antibiotic medicines for sixty days. The vaccine
treatment is designed to prevent the disease. It is considered experimental
because it has not been approved for use by people who already have
breathed the anthrax bacteria.
VOICE ONE:
These incidents have spread fear and confusion
across the country. They are also leading scientists to learn more about
anthrax.Until the recent attacks, American scientists believed that
particles of anthrax bacteria settled on a surface and did not move
about in the air again.
But results from tests inside some affected
buildings found that a number of particles entered the air again when
investigators re-entered the buildings. And a test of mail-handling
equipment found that even a machine that was partly cleaned still released
anthrax into the air.
Officials from the Centers for Disease Control
want to test different drugs for the disease. Other agencies are planning
still more investigations. They want to learn how many particles it
takes to infect a person with anthrax. They want to learn what health
conditions make a person more likely than others to develop the disease.
They also want to know what drugs are the most
effective treatments. And they want to know what would happen if the
bacteria were released in an area where there are many people instead
of through the mail.
((MUSIC BRIDGE))
VOICE TWO:
Another major science story of last year was
the continued struggle against the H-I-V virus and the disease it causes,
AIDS. The United Nations says about forty-million people are living
with H-I-V and AIDS around the world. That is an increase of about four-million
from the year before. Officials say about three-million people died
from the disease last year.
African countries have been most seriously affected.
About seventy percent of all people infected with the disease live in
Africa. More than three-million people in Africa were infected last
year. Were it not for AIDS, life expectancy among Africans would be
about sixty-two years instead of forty-seven.
AIDS victims in Burundi
The United Nations recently reported that AIDS is now spreading fastest
in eastern Europe, especially Ukraine. The number of infections in Russia
also has greatly increased. AIDS rates also have risen in Asia and the
Middle East. An increase in dangerous sexual activities is leading to
higher infection rates in some industrial countries.
However, some nations have reduced their number
of AIDS cases. For example, Thailand, Brazil and Uganda have led successful
treatment and prevention campaigns. These efforts also have reduced
the number of babies born with the virus.
VOICE ONE:
The U-N General Assembly held it first conference
about AIDS last year. More than three-thousand government leaders, health
experts, activists and patients took part. At the meeting, the U-N established
an international program to finance treatment and prevention efforts.
Countries have promised about two-thousand-million dollars so far. Secretary-General
Kofi Annan says the program needs at least seven-thousand-million dollars.
Some of the world's largest drug companies have
sharply reduced the prices of powerful AIDS drugs for developing countries.
But AIDS experts say this will have a limited effect until other problems
are solved. For example, may Africans are not tested for the disease.
Many African countries do not have the necessary
medical equipment to carry out needed blood tests. And few doctors know
how to give AIDS drugs and supervise their use. But other experts say
enough medical centers do exist to support AIDS drug programs in Africa.
They say these problems can be solved.
((THEME))
VOICE TWO:
This SCIENCE IN THE NEWS program was written
by Cynthia Kirk, Mario Ritter and Nancy Steinbach. It was produced by
Caty Weaver. This is Doug Johnson.
VOICE ONE:
And this is Bob Doughty. Join us again next
week for more news about science in Special English on the Voice of
America.
万千英语族关于VOA Special English听力材料的特别说明:
- 本站收集整理、转载VOA Special English之音频及文本仅出于方便英语爱好者学习英语,练习听力之目的,不代表本站赞同VOA之任何观点。
- 新闻一般都有其倾向性,VOA做为境外站点,其新闻报导的倾向性必然带有其自身的目的,本站作为公益性英语学习站点,在收集资料时力求不损害国家和民族之利益,对于明显与主流媒体观点不一致的资料已经进行了删减,但是由于我们自身的局限性,可能对于个别篇章把握尺度不够严格,若您在使用这些听力资料时发现个别材料不合适,请与我们联系处理。更多信息,请点击关于我们链接获得。
- 本站VOA Special English音频资料为rm格式,需要安装RealPlayer 或 RealOne方可使用,关于RealPlayer下载、安装使用等问题,请访问其官方站点http://www.real.com/products/player。若您需要mp3格式文件,请下载RM格式文件后自行转换。
|
|